Yale Researchers Develop RNA-Based Therapy That Can Protect From Range of COVID-19 Variants

SLR14 Reduces Pneumonia COVID

Compared with a control (left), treatment with SLR14 (right) reduces the signs of inflammation and pneumonia in the lungs of SARS-CoV-2–infected mice. Credit: ©2021 Mao et al. Originally published in Journal of Experimental Medicine. https://doi.org/10.1084/jem.20211818

Researchers at Yale School of Medicine have discovered that an RNA molecule that stimulates the body’s early antiviral defense system can protect mice from a range of emerging SARS-CoV-2 variants. The study, published recently in the Journal of Experimental Medicine (JEM), could lead to new treatments for COVID-19 in immunocompromised patients, as well as providing an inexpensive therapeutic option for developing countries that currently lack access to vaccines.

Though approved vaccines against SARS-CoV-2 are highly effective at preventing severe disease and death during the ongoing COVID-19 pandemic, vaccine availability is extremely limited in many low-income countries, and new, vaccine-resistant strains of the virus could emerge in the future. Moreover, the vaccines’ effectiveness is already reduced in immunocompromised individuals unable to form sufficient numbers of antibodies or T cells that specifically target the viral spike protein. These individuals are susceptible to chronic, long-term SARS-CoV-2 infections.

“This is why, in addition to the use of vaccines in preventing COVID-19, efforts are required to develop efficacious therapeutics against SARS-CoV-2,” says Akiko Iwasaki, a professor at Yale School of Medicine.

The body’s first line of defense against SARS-CoV-2—before the involvement of antibodies and T cells—is thought to depend on receptor molecules such as RIG-I that recognize the virus’s genetic material and induce the production of signaling proteins known as type I interferons. These interferons, in turn, promote the production of proteins that can inhibit viral replication and stimulate the recruitment of immune cells to fight the infection.

Multiple studies have suggested that early and robust production of interferons protects against COVID-19, whereas delayed production is associated with severe disease. A clinical trial has shown that treating COVID-19 patients with purified interferon protein early during disease can reduce mortality, but manufacturing interferons is extremely expensive.

In the new JEM study, Iwasaki and colleagues suggest a cheaper alternative: treating patients with short RNA molecules that mimic SARS-CoV-2’s genetic material and activate the RIG-I receptor to stimulate production of type I interferons by the body’s own cells.

The researchers tested their approach in mice susceptible to SARS-CoV-2 infection. A single dose of an RNA molecule named SLR14 was sufficient to protect the mice from severe disease and death, particularly if the treatment was provided shortly before or soon after exposure to the virus. When administered shortly after viral infection, SLR14 was more effective than treating mice with purified interferon protein, the researchers determined.

Crucially, SLR14 protected mice from all emerging SARS-CoV-2 variants, including the delta variant responsible for the recent surge in US COVID-19 cases.

Finally, Iwasaki and colleagues tested SLR14 in immunocompromised Rag/ mice chronically infected with SARS-CoV-2. The RNA molecule was able to completely clear the virus from these animals, even though they lack both T cells and antibody-producing B cells.

Iwasaki and colleagues point out that RNA molecules like SLR14 are relatively cheap and easy to manufacture. “SLR14 therefore holds great promise as a new class of RNA therapeutics that can be applied as antivirals against SARS-CoV-2,” Iwasaki says. “Moreover, because this RNA-based therapeutic approach is simple and versatile, our study will facilitate pandemic preparedness and response against future respiratory pathogens sensitive to type I interferons.”

Reference: ” A stem-loop RNA RIG-I agonist protects against acute and chronic SARS-CoV-2 infection in mice” by Tianyang Mao, Benjamin Israelow, Carolina Lucas, Chantal B.F. Vogels, Maria Luisa Gomez-Calvo, Olga Fedorova, Mallery I. Breban, Bridget L. Menasche, Huiping Dong, Melissa Linehan, Yale SARS-CoV-2 Genome Surveillance Initiative, Craig B. Wilen, Marie L. Landry, Nathan D. Grubaugh, Anna M. Pyle and Akiko Iwasaki, 10 November 2021, Journal of Experimental Medicine (JEM).
DOI: 10.1084/jem.20211818

Note: This article have been indexed to our site. We do not claim legitimacy, ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
Oceans Break Heat Record for Third Year in a Row thumbnail

Oceans Break Heat Record for Third Year in a Row

Last year broke the record from 2020 by about 14 zettajoules, or 20 times the world’s annual energy consumptionAn Arvor float is deployed from the RV Pourquoi Pas to capture ocean temperature data. The oceans are absorbing more heat as climate change advances. Credit: Argo Program The world’s oceans reached their hottest levels on record…
Read More
Spam-Anrufe von Wiener Nummer: “This is the police” thumbnail

Spam-Anrufe von Wiener Nummer: “This is the police”

© APA/dpa/Julian Stratenschulte / Julian Stratenschulte Digital Life Fake-Anrufe haben österreichweit zugenommen. Den Opfern wird ein Kriminalfall vorgetäuscht. Eine Betrugswelle, vor der die Meldestelle für Rufnummermissbrauch bereits Mitte Jänner gewarnt hatte, hat ihren weiteren Verlauf genommen. Nicht nur in Wien, sondern auch in der Steiermark und in Oberösterreich wurden vermehrt Fake-Anrufe gemeldet, bei denen sich Betrüger*innen…
Read More
Solar cells for IoT devices with AI-powered energy management thumbnail

Solar cells for IoT devices with AI-powered energy management

As the number of Internet of Things devices is rapidly increasing, there is an urgent need for sustainable and efficient energy sources and management practices in ambient environments. In response, Newcastle University researchers have created environmentally friendly, high-efficiency photovoltaic cells that harness ambient light to power Internet of Things (IoT) devices. The research team from
Read More
Cette lentille de contact affiche des notifications sur votre œil thumbnail

Cette lentille de contact affiche des notifications sur votre œil

InWith annonce les premières lentilles de contact souples capables d'afficher des informations directement sur l'œil. Elles peuvent également corriger la vue.Cela vous intéressera aussi [EN VIDÉO] Kezako : peut-on vraiment faire confiance à nos yeux ?  L’œil humain peut différencier près de huit millions de nuances de couleurs. Pourtant, cet organe si avancé ne donne…
Read More
Index Of News
Consider making some contribution to keep us going. We are donation based team who works to bring the best content to the readers. Every donation matters.
Donate Now

Subscription Form

Liking our Index Of News so far? Would you like to subscribe to receive news updates daily?

Total
0
Share